PublizoomAward notice Supplies
Alimentation parentérale
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- CHIREC
Bruxelles (Auderghem) - Place of performance
- 1160 Bruxelles (Auderghem), Brussels-Capital
- Amount awarded
- €687,843 excl. VAT
- Planned end of contract
- 9 September 2030
likely re-tender around March 2030 - Bids received
- 2
- Procedure
- Open procedure
Any company may submit a bid. - Publication
- 9 October 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Alimentation parentérale
Awarded to
- Fresenius Kabi BCE/KBO 0458.813.760
2 lots
- Poches d'alimentation parentérale ternaires pour administration par IVC et IVP, avec électrolytes, pour patients adultes.
- Solution injectable de vitamines et oligo-éléments pour patients adultes
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33692200
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
| Raamovereenkomst voor afname van dialyseconcentraten AZ Sint-Lucas vzw · 21 October 2026 |
HEMOTECH BELUX | €1,128,000 |
| Acquisition de produits reactifs pour les sequenceurs illumina Université Libre de Bruxelles · 20 October 2026 |
ILLUMINA BELGIUM | €410,000 |
| Aankoop en levering van Single Cell kits VIB vzw · 7 October 2026 |
10x Genomics | €447,864 |
| Raamovereenkomst voor de levering van Tocilizumab AZ Sint-Lucas vzw · 7 October 2026 |
Celltrion Healthcare Netherlands B.V. | €1,229,160 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 700307-2026.